1. Identification of tumor antigens and immune subtypes of cholangiocarcinoma for mRNA vaccine development
   Xing Huang et al, 2021, Molecular Cancer CrossRef
2. Liver transplantation for intrahepatic and hilar cholangiocellular carcinoma: Most recent updates in the literature
   Susumu Eguchi et al, 2022, Annals of Gastroenterological Surgery CrossRef
3. Long-Term Recurrence-Free and Overall Survival Differ Based on Common, Proliferative, and Inflammatory Subtypes After Resection of Intrahepatic Cholangiocarcinoma
   Laura Alaimo et al, 2023, Annals of Surgical Oncology CrossRef
4. The Functional Roles of Immune Cells in Primary Liver Cancer
   Linh Pham et al, 2022, The American Journal of Pathology CrossRef
5. Efficacy and safety analysis of chemotherapy combined with immunotherapy compared with standard chemotherapy for advanced biliary tract malignant tumors
   Zhengfeng Zhang et al, 2023, Cancer Medicine CrossRef
6. Timeline of FDA-Approved Targeted Therapy for Cholangiocarcinoma
   Su Min Cho et al, 2022, Cancers CrossRef
7. Cholangiocarcinoma and liver transplantation: What we know so far?
   Ali Reza Safarpour et al, 2021, World Journal of Gastrointestinal Pathophysiology CrossRef
8. Non-surgical treatment of hilar cholangiocarcinoma
   Riccardo Inchingolo et al, 2021, World Journal of Gastrointestinal Oncology CrossRef
9. High-Molecular-Weight Fractions of Spruce and Eucalyptus Lignin as a Perspective Nanoparticle-Based Platform for a Therapy Delivery in Liver Cancer
   Ievgen V. Pylypchuk et al, 2022, Frontiers in Bioengineering and Biotechnology CrossRef
10. Micro-RNA in Cholangiocarcinoma: Implications for Diagnosis, Prognosis, and Therapy
    Anna Barbato et al, 2022, Journal of Molecular Pathology CrossRef
11. Interventions for unresectable intrahepatic cholangiocarcinoma: a network meta-analysis
    null null et al, 2022, Cochrane Database of Systematic Reviews CrossRef
12. Real-world outcomes of patients with advanced intrahepatic cholangiocarcinoma treated with programmed cell death protein-1-targeted immunotherapy
    Min Deng et al, 2022, Annals of Medicine CrossRef
13. The State of Immunotherapy in Hepatobiliary Cancers
    Farhan Z. Ilyas et al, 2021, Cells CrossRef
14. Clinical treatment of cholangiocarcinoma: an updated comprehensive review
    Alessandra Elvevi et al, 2022, Annals of Hepatology CrossRef
15. Comparison of the effectiveness of chemotherapy combined with immunotherapy and chemotherapy alone in advanced biliary tract cancer and construction of the nomogram for survival prediction based on the inflammatory index and controlling nutritional status score
    Zhengfeng Zhang et al, 2023, Cancer Immunology, Immunotherapy CrossRef
16. Discovery of lung adenocarcinoma tumor antigens and ferroptosis subtypes for developing mRNA vaccines
    Yan Chen et al, 2024, Scientific Reports CrossRef
17. ASO Author Reflections: Common, Proliferative, and Inflammatory Subtypes of Intrahepatic Cholangiocarcinoma
    Laura Alaimo et al, 2023, Annals of Surgical Oncology CrossRef
18. Review and Application of Integrin Alpha v Beta 6 in the Diagnosis and Treatment of Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma
    Yunyu Lian et al, 2023, Technology in Cancer Research & Treatment CrossRef
19. Response Assessment of Primary Liver Tumors to Novel Therapies: an Imaging Perspective
    Golnoosh Ansari et al, 2023, Journal of Gastrointestinal Surgery CrossRef
20. Novel Pharmacological Options in the Treatment of Cholangiocarcinoma: Mechanisms of Resistance
    Jose J. G. Marin et al, 2021, Cancers CrossRef
21. Crosstalk Between Four Types of RNA Modification Writers Characterizes the Tumor Immune Microenvironment Infiltration Patterns in Skin Cutaneous Melanoma
    Shichao Zhang et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
22. Radiomics of Biliary Tumors: A Systematic Review of Current Evidence
    Francesco Fiz et al, 2022, Diagnostics CrossRef